BMY Financial Facts
Other (income)/expense: -26MProvision for income taxes: 475M
See Full Income Statement
Total Liabilities and Equity: 32.01B
Pension, postretirement, and postemployment liabilities: 811M
See Full Balance Sheet
Bristol-Myers Squibb Company (BMY) Earnings
|
Expand Research on BMY
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +1.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/27/22 |  |
Q222 | N/A | $1.88 | N/A | N/A | $11.41B | N/A | N/A | N/A | |
| 4/29/22 | |
Q122 | $1.96 | $1.94 | +$0.02 | $11.65B | $11.42B | N/A |  | | Details |
| 2/4/22 | |
Q421 | $1.83 | $1.82 | +$0.01 | $12B | $12.12B | N/A | | | Details |
| 10/27/21 | |
Q321 | $2.00 | $1.94 | +$0.06 | $11.62B | $11.64B | N/A | | | Details |
| 7/28/21 | |
Q221 | $1.93 | $1.91 | +$0.02 | $11.7B | $11.33B | N/A | | | Details |
| 4/29/21 | |
Q121 | $1.74 | $1.81 | -$0.07 | $11.1B | $11.11B | N/A | | | Details |
| 2/4/21 | |
Q420 | $1.46 | $1.41 | +$0.05 | $11.07B | $10.73B | N/A | | | Details |
| 11/5/20 | |
Q320 | $1.63 | $1.49 | +$0.14 | $10.5B | $10.33B | N/A | | | Details |
